ImmunoPrecise Antibodies Revenue (TTM) Insights

ImmunoPrecise Antibodies Ltd (IPA)

1.28 -0.02 (-1.54%) USD | NASDAQ | May 07, 16:00

1.28 0.00 (0.00%) After-Hours: 20:00

Revenue (TTM) Chart

Historical Revenue (TTM) Data

View and export this data back to 1997. Upgrade now.

Date	Value
January 31, 2024	17.54M
October 31, 2023	16.77M
July 31, 2023	16.13M
April 30, 2023	15.51M
January 31, 2023	15.50M
October 31, 2022	15.47M
July 31, 2022	15.33M
April 30, 2022	15.42M
January 31, 2022	15.16M
October 31, 2021	14.87M
July 31, 2021	14.71M
April 30, 2021	13.73M
January 31, 2021	12.87M
October 31, 2020	12.43M
July 31, 2020	11.22M
April 30, 2020	10.52M
January 31, 2020	9.482M
October 31, 2019	8.440M
July 31, 2019	8.135M
April 30, 2019	8.292M
January 31, 2019	7.731M
October 31, 2018	7.070M
July 31, 2018	6.039M
April 30, 2018	4.284M
January 31, 2018	3.309M

Date	Value
October 31, 2017	2.329M
July 31, 2017
April 30, 2017
January 31, 2017
September 30, 2016
June 30, 2016
March 31, 2016
December 31, 2015
September 30, 2015
June 30, 2015
March 31, 2015
December 31, 2014
September 30, 2014
June 30, 2014
March 31, 2014
December 31, 2013
September 30, 2013
June 30, 2013
March 31, 2013
December 31, 2012
September 30, 2012
June 30, 2012
March 31, 2012
December 31, 2011
September 30, 2011

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (TTM) Range, Past 5 Years

8.135M

Minimum

Jul 2019

17.54M

Maximum

Jan 2024

13.64M

Average

14.87M

Median

Oct 2021

Revenue (TTM) Benchmarks